This item requires a subscription to Journal of Pharmacology and Experimental Therapeutics.
Cover
Full Text (PDF)
INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA:
  • John Doukas,
  • Lisa Eide,
  • Karin Stebbins,
  • Adrienne Racanelli-Layton,
  • Luis Dellamary,
  • Michael Martin,
  • Elena Dneprovskaia,
  • Glenn Noronha,
  • Richard Soll,
  • Wolfgang Wrasidlo,
  • Lisette M. Acevedo,
  • and David A. Cheresh
Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease J Pharmacol Exp Ther March 2009 328:758-765; published ahead of print December 4, 2008, doi:10.1124/jpet.108.144311
To view this item, select one of the options below:

This Article

  1. Published online before print December 4, 2008, doi: 10.1124/jpet.108.144311 JPET March 2009 vol. 328 no. 3 758-765
  1. Show PDF in full window
  2. AbstractFree
  3. Full Text
  4. » Full Text (PDF)

Responses

  1. Submit a response
  2. No responses published

Current Issue

  1. November 2009, 331 (2)
  1. Current Issue
  1. Alert me to new issues of JPET